SCH532706

A CCR5 antagonist being developed by Schering-Pough.

Good news, bad news: report from CROI

Positive Living article • John Daye • 26 March 2008

John Daye, NAPWA's Health, Treatments & Research Portfolio Co-Convenor reports from the 15th Conference on Retroviruses and Opportunistic Infections (CROI) held in Boston, USA from 3-6 February 2008 read more »

Text size:

Stay in touch

Subscribe to newsletters

NAPWA's email newsletters provide regular info about issues affecting people with HIV and the response to HIV in Australia. Click here to subscribe.

Subscribe to Positive Living

Our free quarterly newsmagazine, Positive Living provides authoritative, independent information about living with HIV and HIV treatments. Click here to subscribe.

RSS feeds

Our website has RSS feeds covering all topic areas — just go to the topic area you're interested in and click the RSS feed icon.

Follow NAPWA on Twitter

Twitter users can stay up-to-date with NAPWA's work and be alerted to new content on the website by following @napwa.

Most-read content

The most-read articles over the last few days.

Give your vagina a choice (50)
A checklist guide for people with HIV (37)
HIV is a virus not a crime (28)
Mouth ulcers & other mouth conditions (21)
Can we stop HIV now? (18)

HIV Clinical Trials update

Recently updated entries from the NAPWA Clinical Trials database.

Gardasil for young men
Reported
ENCORE-1
Fully enrolled
Second line
Fully enrolled
VERxVE (fast and slow release nevirapine)
Reported
Famciclovir for genital herpes
No longer enrolling

NAPWA

Navigation

Health on the Net Foundation Certified

User login